Aquatic Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Aquatic Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	+19,076	New	+$1.1M	0.04%	538
2026 Q1	–	Sell	-30,016	Closed	-$1.62M	–	1391
2025 Q4	$1.62M	Sell	30,016 -1,029,029	-97%	-$49.5M	0.05%	425
2025 Q3	$47.8M	Buy	1,059,045 +850,758	+408%	+$39.7M	0.89%	12
2025 Q2	$9.64M	Buy	+208,287	New	+$10.2M	0.19%	136
2024 Q4	–	Sell	-220,600	Closed	-$11.4M	–	1346
2024 Q3	$11.4M	Sell	220,600 -588,400	-73%	-$27.6M	0.3%	93
2024 Q2	$33.6M	Buy	+809,000	New	+$36.2M	1.24%	13
2024 Q1	–	Sell	-76,200	Closed	-$3.91M	–	1241
2023 Q4	$3.91M	Sell	76,200 -248,300	-77%	-$13M	0.1%	209
2023 Q3	$18.8M	Buy	324,500 +239,900	+284%	+$14.7M	0.79%	27
2023 Q2	$5.41M	Buy	84,600 +3,100	+4%	+$208K	0.29%	83
2023 Q1	$5.65M	Sell	81,500 -191,300	-70%	-$13.5M	0.35%	75
2022 Q4	$19.6M	Buy	+272,800	New	+$20.6M	1.43%	5

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aquatic Capital Management's BMY Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 19,076 shares worth $1.1M. The stake represents 0.04% of the portfolio and ranks #538 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in BMY as recently as Q4 2025.

Aquatic Capital Management first reported a position in BMY in Q4 2022 and has held it in 11 quarters since. The position peaked at $47.8M in Q3 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Aquatic Capital Management held 19,076 shares of Bristol-Myers Squibb worth $1.1M as of Q2 2026.
Bristol-Myers Squibb was a new Aquatic Capital Management position in Q2 2026.
Bristol-Myers Squibb made up 0.04% of Aquatic Capital Management's portfolio in Q2 2026, its #538 holding.
Aquatic Capital Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 11 quarters since.
Aquatic Capital Management's Bristol-Myers Squibb position peaked at $47.8M in Q3 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.